Cheryl Cohen

Cheryl L.
Cohen was the founder of CLC Consulting LLC, founded in 2008, serving as President from 2008 to 2011.
Current jobs include Director at Aerpio Therapeutics LLC since 2018, Independent Director at Celldex Therapeutics, Inc. since 2022, and Lead Independent Director at ImmunityBio, Inc. since 2023.
Former jobs include Independent Director at LadRx Corp.
(2015–2016), Director at Protein Sciences Corp.
(2014–2017), Independent Director at NantKwest, Inc., Independent Non-Executive Director at Lite Strategy, Inc. (2020–2022), Independent Director at Vital Therapies, Inc. (2015–2019), Independent Director at Aerpio Pharmaceuticals, Inc. (2018–2021), Independent Director at Eledon Pharmaceuticals, Inc. (2015–2020), Independent Director at Ignyte Acquisition Corp., Independent Director at Tokai Pharmaceuticals, Inc. (2015–2020), Vice President-Rheumatology Franchise at Centocor, Inc. (1998–2007), Vice President-Rheumatology Franchise at Johnson & Johnson, Principal at Solvay Pharmaceuticals, Inc. (1998), Vice President-Strategic Commercial Group at Health Care Systems, Inc. (2007–2008), Chief Commercial Officer at Medivation LLC (California) (2011–2014), and Vice President-Rheumatology Franchise at Janssen Biotech, Inc. (1998–2007).
Education includes undergraduate studies at Saint Joseph College.